search

Active clinical trials for "Heart Diseases"

Results 1941-1950 of 3529

Follow-up Safety Trial in Children With Chronic Heart Failure Therapy Receiving Orodispersible Minitablets...

Heart FailureDilated Cardiomyopathy1 more

Paediatric long-term safety follow-up clinical trial in maximum 100 children with heart failure due to dilated cardiomyopathy or congenital heart disease, from 1 day to less than 12 years of age at recruitment into the preceding short-term pharmacokinetic (PK)/pharmacodynamic (PD) trials. Pharmacodynamic measurements and renal monitoring in all children after 1 , 4, 7 and 10 months of follow-up; in addition PK assessments as well as acceptability and palatability assessments in children still under enalapril Orodispersible Minitablet (ODMT) treatment.

Unknown status4 enrollment criteria

Effect of Resistance Training in Adults With Complex Congenital Heart Disease

Congenital Heart Defect

Adults with complex congenital heart disease have impaired muscle function compared both to health controls and patients with lesions classified as simple. There is only one study assessing the effects of resistance training in patients palliated with Fontan procedure. The hypotheses of the present study is that home based resistance training will improve muscle function in adults with different complex congenital hear diseases.

Unknown status8 enrollment criteria

Clinical Study of Combination Therapy for Angina of Coronary Heart Disease With Aspirin and Salvianolate...

Angina

To evaluate the therapeutic evaluation of combination therapy with aspirin and salvianolate injection based on the population pharmacokinetics and TEG.A prospective, multicenter, randomized, controlled clinical trial is used.A total of 120 patients will be recruited and will be divided into three groups,respectively salvianolate injection group,aspirin group and salvianolate injection and aspirin group,and the course of treatment is 10 days.

Unknown status16 enrollment criteria

Sirolimus Eluting ORSIRO Stent Versus Biolimus-eluting NOBORI Stent

Coronary Artery DiseaseIschemic Heart Disease

The aim of the Danish Organization for Randomized Trials with Clinical Outcome (SORT OUT) is to compare the safety and efficacy of the sirolimus eluting ORSIRO stent and the biolimus-eluting NOBORI stent in a population-based setting, using registry detection of clinically driven events

Unknown status1 enrollment criteria

Randomized Control Trial to Evaluate Effectiveness of a Case Managment Program Regarding Psychosocial...

Coronary Heart DiseaseMultimorbidity

This randomized controlled trial (RCT) will examine a case management program for patients suffering from coronary heart disease with multimorbidity in Mannheim, Germany. The trail consists of 3 treatment arms: 1) intensified case management; 2) social interaction alone 3) standard care. The main objectives are to evaluate how case management and social interaction alone compared to standard medical care affect the primary and secondary outcomes: physical health, quality of life, loneliness, depression, self-efficacy, outcome expectancies, social support, health locus of control, lifestyle behavior, social network, vulnerability, intention, severity, health worries and cognitive functions.

Unknown status8 enrollment criteria

Strategies for Revascularization in Patients Undergoing Heart Valve Surgery With Concomitant Coronary...

Coronary Artery DiseaseValvular Heart Disease

The purpose of this study is to determine whether, in patients undergoing elective valvular heart surgery, revascularization of concomitant coronary artery disease (CAD) guided by FFR (Fractional flow reserve) would be superior to standard angiography-guided-revascularization approach on major efficacy and safety outcomes

Unknown status14 enrollment criteria

The Study of Active Transfer of Plaque Technique for Non-Left Main Coronary Bifurcation Lesions...

Coronary Heart Disease

A Prospective Multi-center Randomized Trial Assessing the Efficacy and Safety of Active Transfer of Plaque vs. Provisional T Stenting for the Treatment of Non-Left-Main Coronary Bifurcation Lesions.

Unknown status16 enrollment criteria

Evaluate Safety And Effectiveness Of The Tivoli® DES and The Firebird2® DES For Treatment Coronary...

Ischemic Heart DiseaseMyocardial Ischemia4 more

This is a prospective, multi-center, open label, randomized study to evaluate the efficacy and safety of The TIVOLI Biodegradable polymer Rapamycin-Eluting Stent comparing with The FIREBIRD2™ Rapamycin-eluting Stent (DES) for Treatment Coronary Revascularization.

Unknown status21 enrollment criteria

Ranolazine for Improving Symptoms of Palpitations

Ischemic Heart Disease

Patients with ischemic heart disease often report multiple symptoms, including angina and palpitations. Ranolazine has antiarrhythmic effects which are largely a result of the drug's effect on multiple ion channels. It remains unknown, however, whether the favorable effects of ranolazine on symptoms and arrhythmias are maintained over time. Aim of this study is to test the hypothesis that chronic treatment with ranolazine can improve the symptomatic status of patients with ischemic heart disease by reducing the occurrence of palpitations.

Unknown status9 enrollment criteria

Treatment of Coronary Atherosclerosis by Insulin Sensitizers in Insulin-Resistant Patients

Coronary AtherosclerosisInflammation1 more

In this study, we, the investigators at National Taiwan University Hospital, will evaluate the efficacy of pharmacological therapy targeted to reduce insulin resistance (pioglitazone) on the progression and compositional change of non-obstructive coronary atherosclerotic plaques and coronary calcification by serial intravascular ultrasound (IVUS)/multi-detector-row computed tomography (MDCT) follow-up in patients with type 2 diabetes or non-diabetic metabolic syndrome during a 2-year period.

Unknown status19 enrollment criteria
1...194195196...353

Need Help? Contact our team!


We'll reach out to this number within 24 hrs